← Every company

Halozyme Therapeutics Inc SEC Filings

What Halozyme Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

HALO overview →
Filings on file
143
since Nov 7, 2016
Warning signs
2
latest Nov 12, 2019
Last results
Aug 6, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 22, 2026
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Aug 18, 2026
Executive or director change
8-K
Read ↗
Aug 6, 2026
Quarterly report
10-Q
Read ↗
Aug 6, 2026
Results announced
8-K
Read ↗
Jul 2, 2026
Executive or director change
8-K
Read ↗
May 11, 2026
Quarterly report
10-Q
Read ↗
May 11, 2026
Results announced
8-K
Read ↗
May 7, 2026
Shareholder vote
8-K
Read ↗
Apr 30, 2026
Executive or director change
8-K
Read ↗
Mar 12, 2026
Executive or director change
8-K
Read ↗
Feb 17, 2026
Annual report
10-K
Read ↗
Feb 17, 2026
Results announced
8-K
Read ↗
Jan 28, 2026
Results announced
8-K
Read ↗
Dec 9, 2025
Executive or director change
8-K
Read ↗
Dec 8, 2025
Executive or director change
8-K
Read ↗
Nov 24, 2025
Executive or director change
8-K
Read ↗
Nov 12, 2025
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Nov 5, 2025
Material agreementNew debt
8-K
Read ↗
Nov 3, 2025
Quarterly report
10-Q
Read ↗
Nov 3, 2025
Executive or director changeResults announced
8-K
Read ↗
Oct 6, 2025
Executive or director change
8-K
Read ↗
Oct 3, 2025
Material agreement
8-K
Read ↗
Aug 5, 2025
Quarterly report
10-Q
Read ↗
Aug 5, 2025
Results announced
8-K
Read ↗
May 6, 2025
Quarterly report
10-Q
Read ↗
May 6, 2025
Results announced
8-K
Read ↗
May 2, 2025
Shareholder vote
8-K
Read ↗
Mar 21, 2025
Executive or director change
8-K
Read ↗
Feb 18, 2025
Annual report
10-K
Read ↗
Feb 18, 2025
Results announced
8-K
Read ↗
Feb 13, 2025
Executive or director change
8-K
Read ↗
Jan 8, 2025
Results announced
8-K
Read ↗
Oct 31, 2024
Quarterly report
10-Q
Read ↗
Oct 31, 2024
Results announced
8-K
Read ↗
Aug 6, 2024
Quarterly report
10-Q
Read ↗
Aug 6, 2024
Results announced
8-K
Read ↗
May 7, 2024
Quarterly report
10-Q
Read ↗
May 7, 2024
Results announced
8-K
Read ↗
Apr 26, 2024
Shareholder vote
8-K
Read ↗
Feb 20, 2024
Annual report
10-K
Read ↗
Feb 20, 2024
Results announced
8-K
Read ↗
Jan 17, 2024
Results announced
8-K
Read ↗
Nov 6, 2023
Quarterly report
10-Q
Read ↗
Nov 6, 2023
Results announced
8-K
Read ↗
Aug 8, 2023
Quarterly report
10-Q
Read ↗
Aug 8, 2023
Results announced
8-K
Read ↗
May 9, 2023
Quarterly report
10-Q
Read ↗
May 9, 2023
Results announced
8-K
Read ↗
May 8, 2023
Shareholder vote
8-K
Read ↗
Feb 23, 2023
Executive or director change
8-K
Read ↗
Feb 21, 2023
Annual report
10-K
Read ↗
Feb 21, 2023
Results announced
8-K
Read ↗
Feb 6, 2023
Executive or director change
8-K
Read ↗
Jan 10, 2023
Results announced
8-K
Read ↗
Nov 8, 2022
Quarterly report
10-Q
Read ↗
Nov 8, 2022
Results announced
8-K
Read ↗
Aug 19, 2022
Material agreementNew debt
8-K
Read ↗
Aug 18, 2022
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Aug 9, 2022
Quarterly report
10-Q
Read ↗
Aug 9, 2022
Results announced
8-K
Read ↗
May 24, 2022
Acquisition or sale completedMaterial agreementNew debt
8-K
Read ↗
May 10, 2022
Quarterly report
10-Q
Read ↗
May 10, 2022
Results announced
8-K
Read ↗
May 6, 2022
Shareholder vote
8-K
Read ↗
Apr 26, 2022
Tender offer
SC TO-T
Read ↗
Apr 13, 2022
Material agreement
8-K
Read ↗
Mar 21, 2022
Material agreementNew debt
8-K
Read ↗
Mar 15, 2022
Executive or director change
8-K
Read ↗
Feb 22, 2022
Annual report
10-K
Read ↗
Feb 22, 2022
Results announced
8-K
Read ↗
Feb 3, 2022
Executive or director change
8-K
Read ↗
Jan 10, 2022
Results announced
8-K
Read ↗
Dec 29, 2021
Material agreementNew debt
8-K
Read ↗
Dec 13, 2021
Executive or director change
8-K
Read ↗
Nov 2, 2021
Results announced
8-K/A
Read ↗
Nov 2, 2021
Quarterly report
10-Q
Read ↗
Nov 2, 2021
Acquisition or sale completed
8-K
Read ↗
Aug 9, 2021
Quarterly report
10-Q
Read ↗
Aug 9, 2021
Results announced
8-K
Read ↗
May 10, 2021
Quarterly report
10-Q
Read ↗
May 10, 2021
Results announced
8-K
Read ↗
May 7, 2021
Shareholder vote
8-K
Read ↗
May 5, 2021
Executive or director change
8-K
Read ↗
May 3, 2021
Executive or director change
8-K
Read ↗
Mar 1, 2021
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Feb 23, 2021
Annual report
10-K
Read ↗
Feb 23, 2021
Results announced
8-K
Read ↗
Jan 13, 2021
Results announced
8-K
Read ↗
Jan 11, 2021
Results announced
8-K
Read ↗
Nov 2, 2020
Quarterly report
10-Q
Read ↗
Nov 2, 2020
Results announced
8-K
Read ↗
Aug 10, 2020
Quarterly report
10-Q
Read ↗
Aug 10, 2020
Results announced
8-K
Read ↗
May 11, 2020
Quarterly report
10-Q
Read ↗
May 11, 2020
Results announced
8-K
Read ↗
May 4, 2020
Shareholder vote
8-K
Read ↗
Feb 24, 2020
Annual report
10-K
Read ↗
Feb 24, 2020
Executive or director change
8-K
Read ↗
Feb 24, 2020
Results announced
8-K
Read ↗
Jan 14, 2020
Results announced
8-K
Read ↗
Nov 18, 2019
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Nov 12, 2019
Material impairmentRestructuring
8-K/A
Read ↗
Nov 12, 2019
Quarterly report
10-Q
Read ↗
Nov 12, 2019
Results announced
8-K
Read ↗
Nov 5, 2019
Material impairmentExecutive or director changeRestructuring
8-K
Read ↗
Aug 6, 2019
Quarterly report
10-Q
Read ↗
Aug 6, 2019
Results announced
8-K
Read ↗
May 7, 2019
Quarterly report
10-Q
Read ↗
May 7, 2019
Results announced
8-K
Read ↗
May 3, 2019
Shareholder vote
8-K
Read ↗
Feb 21, 2019
Annual report
10-K
Read ↗
Feb 21, 2019
Results announced
8-K
Read ↗
Dec 13, 2018
Executive or director change
8-K
Read ↗
Nov 6, 2018
Quarterly report
10-Q
Read ↗
Nov 6, 2018
Results announced
8-K
Read ↗
Sep 10, 2018
Executive or director change
8-K
Read ↗
Aug 7, 2018
Quarterly report
10-Q
Read ↗
Aug 7, 2018
Results announced
8-K
Read ↗
May 10, 2018
Quarterly report
10-Q
Read ↗
May 10, 2018
Results announced
8-K
Read ↗
May 2, 2018
Shareholder vote
8-K
Read ↗
Apr 6, 2018
Executive or director change
8-K
Read ↗
Mar 22, 2018
Executive or director change
8-K
Read ↗
Feb 20, 2018
Annual report
10-K
Read ↗
Feb 20, 2018
Results announced
8-K
Read ↗
Jan 12, 2018
Results announced
8-K
Read ↗
Jan 10, 2018
Results announced
8-K
Read ↗
Nov 7, 2017
Quarterly report
10-Q
Read ↗
Nov 7, 2017
Results announced
8-K
Read ↗
Sep 29, 2017
Executive or director change
8-K
Read ↗
Aug 8, 2017
Quarterly report
10-Q
Read ↗
Aug 8, 2017
Results announced
8-K
Read ↗
Jul 5, 2017
Material agreement
8-K
Read ↗
May 19, 2017
Material agreement
8-K
Read ↗
May 9, 2017
Quarterly report
10-Q
Read ↗
May 9, 2017
Executive or director change
8-K
Read ↗
May 9, 2017
Results announced
8-K
Read ↗
May 5, 2017
Shareholder vote
8-K
Read ↗
Feb 28, 2017
Annual report
10-K
Read ↗
Feb 28, 2017
Results announced
8-K
Read ↗
Jan 9, 2017
Results announced
8-K
Read ↗
Nov 7, 2016
Quarterly report
10-Q
Read ↗
Nov 7, 2016
Results announced
8-K
Read ↗

Source: Halozyme Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on HALO

Related datasets